MA46088A - Procédés d'identification d'épitopes - Google Patents

Procédés d'identification d'épitopes

Info

Publication number
MA46088A
MA46088A MA046088A MA46088A MA46088A MA 46088 A MA46088 A MA 46088A MA 046088 A MA046088 A MA 046088A MA 46088 A MA46088 A MA 46088A MA 46088 A MA46088 A MA 46088A
Authority
MA
Morocco
Prior art keywords
identification processes
epitopic
epitopic identification
processes
identification
Prior art date
Application number
MA046088A
Other languages
English (en)
Inventor
Max Davidson
Owe Orwar
Carolina Trkulja
Original Assignee
Oblique Therapeutics Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oblique Therapeutics Ab filed Critical Oblique Therapeutics Ab
Publication of MA46088A publication Critical patent/MA46088A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/005—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medical Informatics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Library & Information Science (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
MA046088A 2016-09-01 2017-09-01 Procédés d'identification d'épitopes MA46088A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1614884.3A GB201614884D0 (en) 2016-09-01 2016-09-01 Method

Publications (1)

Publication Number Publication Date
MA46088A true MA46088A (fr) 2019-07-10

Family

ID=57140094

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046088A MA46088A (fr) 2016-09-01 2017-09-01 Procédés d'identification d'épitopes

Country Status (14)

Country Link
US (1) US20190194320A1 (fr)
EP (1) EP3507604A1 (fr)
JP (3) JP7032386B2 (fr)
KR (1) KR102441148B1 (fr)
CN (1) CN109791156B (fr)
AU (1) AU2017321032B2 (fr)
GB (1) GB201614884D0 (fr)
IL (1) IL265123B2 (fr)
MA (1) MA46088A (fr)
MX (1) MX2019002455A (fr)
NZ (1) NZ752191A (fr)
RU (1) RU2771584C2 (fr)
SG (1) SG11201901603RA (fr)
WO (1) WO2018042010A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019178151A1 (fr) * 2018-03-13 2019-09-19 Amgen Inc. Procédés de préparation de polypeptides résistant à la trypsine pour analyse par spectrométrie de masse
GB201918103D0 (en) 2019-12-10 2020-01-22 Oblique Therapeutics Ab Epitopes and antibodies
US12605394B2 (en) 2024-07-25 2026-04-21 Visionary Assets, Llc Compositions containing cannabinoid nanoparticles
US12667578B2 (en) 2024-07-25 2026-06-30 Visionary Assets, Llc Cryogenic process for making cannabinoid nanoparticles and compositions made thereby
CN119252379B (zh) * 2024-09-23 2025-06-20 上海分子之心智能科技有限公司 一种预测抗原表位信息的方法、设备、介质及程序产品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2303264C2 (ru) * 2001-02-19 2007-07-20 Мерк Патент Гмбх Способ идентификации эпитопов т-клеток и его применение для получения молекул со сниженной иммуногенностью
UA97086C2 (uk) * 2003-07-15 2012-01-10 Емджен, Інк. Виділене людське антитіло, яке специфічно зв'язується з фактором росту нервової тканини (ngf)
WO2014165271A2 (fr) * 2013-03-13 2014-10-09 Neotope Biosciences Limited Immunothérapie contre tau
MA41842A (fr) * 2015-03-31 2018-02-06 Oblique Therapeutics Ab Nouveaux procédés de sélection d'épitope

Also Published As

Publication number Publication date
BR112019004025A2 (pt) 2019-08-20
MX2019002455A (es) 2019-05-30
RU2019105088A (ru) 2020-10-01
RU2019105088A3 (fr) 2020-12-21
SG11201901603RA (en) 2019-03-28
JP7032386B2 (ja) 2022-03-08
CA3035318A1 (fr) 2018-03-08
IL265123B2 (en) 2024-08-01
IL265123B1 (en) 2024-04-01
AU2017321032B2 (en) 2024-05-30
JP7872469B2 (ja) 2026-06-10
KR20190045252A (ko) 2019-05-02
IL265123A (fr) 2024-04-01
GB201614884D0 (en) 2016-10-19
CN109791156B (zh) 2022-11-22
KR102441148B1 (ko) 2022-09-06
US20190194320A1 (en) 2019-06-27
WO2018042010A1 (fr) 2018-03-08
CN109791156A (zh) 2019-05-21
JP2019536427A (ja) 2019-12-19
NZ752191A (en) 2023-03-31
EP3507604A1 (fr) 2019-07-10
AU2017321032A1 (en) 2019-04-18
RU2771584C2 (ru) 2022-05-06
JP2022033845A (ja) 2022-03-02
JP2024037751A (ja) 2024-03-19

Similar Documents

Publication Publication Date Title
MA55748A (fr) Procédés de détection d'aav
EP4075844C0 (fr) Identifiant d'abonnement caché
EP3430731A4 (fr) Architecture d'iugw
EP3492223A4 (fr) Machine d'entraînement
EP3485955A4 (fr) Purificateur d'air
EP3563977A4 (fr) Système d'outil
EP3422155A4 (fr) Contrôleur d'objet
EP3443293A4 (fr) Capteurs d'effort
EP3558312A4 (fr) Procédés d'amélioration de la densité vasculaire
EP3433383A4 (fr) Procédés d'amplification quantitative
EP3556455A4 (fr) Appareil de production d'urée
MA41298A (fr) Procédés de marquage de banques codées par de l'adn
MA41842A (fr) Nouveaux procédés de sélection d'épitope
EP3485416A4 (fr) Sécurité d'un bios
EP3673476A4 (fr) Identification d'utilisation aérienne erronée
EP2996451A4 (fr) Système d'orientation d'air
MA48596A (fr) Caractéristique d'inertie
MA44972A (fr) Procédés d'identification de modulateurs du cftr
EP3431808A4 (fr) Butée d'arrêt
EP3445974A4 (fr) Réchauffeur d'air
EP3341151A4 (fr) Machine d'oxycoupage au chalumeau
EP3507624A4 (fr) Procédés d'imagerie sismique
EP3285541A4 (fr) Dispositif d'identification
EP3551641A4 (fr) Agents de la staufen1 et procédés associés
EP3554673A4 (fr) Procédés de séparation d'ozone